Search

Your search keyword '"Brain Chemistry drug effects"' showing total 787 results

Search Constraints

Start Over You searched for: Descriptor "Brain Chemistry drug effects" Remove constraint Descriptor: "Brain Chemistry drug effects" Topic dopamine Remove constraint Topic: dopamine
787 results on '"Brain Chemistry drug effects"'

Search Results

1. Developmental exposure to perfluorooctane sulfonate (PFOS) and perfluorooctanoic acid (PFOA) selectively decreases brain dopamine levels in Northern leopard frogs.

2. C-FSCV: Compressive Fast-Scan Cyclic Voltammetry for Brain Dopamine Recording.

3. Mapping the alterations in glutamate with GluCEST MRI in a mouse model of dopamine deficiency.

4. Acute phenylalanine/tyrosine depletion of phasic dopamine in the rat brain.

5. Varenicline-Induced Elevation of Dopamine in Smokers: A Preliminary [(11)C]-(+)-PHNO PET Study.

6. Dopamine D3 receptor antagonism contributes to blonanserin-induced cortical dopamine and acetylcholine efflux and cognitive improvement.

7. The effect of central noradrenergic system lesion on dopamine (DA) and serotonin (5-HT) synthesis rate following administration of 5-HT3 receptor ligands in chosen parts of the rat brain.

8. Consumption of tyrosine in royal jelly increases brain levels of dopamine and tyramine and promotes transition from normal to reproductive workers in queenless honey bee colonies.

9. Pharmacologic inhibition of L-tyrosine degradation ameliorates cerebral dopamine deficiency in murine phenylketonuria (PKU).

10. Effects of VMAT2 inhibitors lobeline and GZ-793A on methamphetamine-induced changes in dopamine release, metabolism and synthesis in vivo.

12. Prenatal exposure to organomercury, thimerosal, persistently impairs the serotonergic and dopaminergic systems in the rat brain: implications for association with developmental disorders.

13. Noradrenergic antidepressants increase cortical dopamine: potential use in augmentation strategies.

14. Serotonergic and dopaminergic distinctions in the behavioral pharmacology of (±)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) and lysergic acid diethylamide (LSD).

15. Alterations of 3,4-dihydroxyphenylethylamine and its metabolite 3,4-dihydroxyphenylacetic produced in rat brain tissues after systemic administration of saxitoxin.

16. Ethanol-induced effects on the dopamine and serotonin systems in adult Wistar rats are dependent on early-life experiences.

17. Isolation rearing-induced reduction of brain 5α-reductase expression: relevance to dopaminergic impairments.

18. The effects of the mGluR5 receptor antagonist 6-methyl-2-(phenylethynyl)-pyridine (MPEP) on the stimulation of dopamine release evoked by nicotine in the rat brain.

19. Maternal high-fat intake alters presynaptic regulation of dopamine in the nucleus accumbens and increases motivation for fat rewards in the offspring.

20. Chronic atrazine exposure causes disruption of the spontaneous locomotor activity and alters the striatal dopaminergic system of the male Sprague-Dawley rat.

21. The roles of dopamine and serotonin in decision making: evidence from pharmacological experiments in humans.

22. Dimebon does not ameliorate pathological changes caused by expression of truncated (1-120) human alpha-synuclein in dopaminergic neurons of transgenic mice.

23. Insulin regulation of monoamine signaling: pathway to obesity.

24. Dopamine uptake inhibitors but not dopamine releasers induce greater increases in motor behavior and extracellular dopamine in adolescent rats than in adult male rats.

25. Binding of dopamine and 3-methoxytyramine as l-DOPA metabolites to human alpha(2)-adrenergic and dopaminergic receptors.

26. Effects of repeated and acute aripiprazole or haloperidol treatment on dopamine synthesis in the dorsal striatum of young rats: comparison to adult rats.

27. Restoration of nigrostriatal dopamine neurons in post-MPTP treatment by the novel multifunctional brain-permeable iron chelator-monoamine oxidase inhibitor drug, M30.

28. [(3)H]4-(Dimethylamino)-N-[4-(4-(2-methoxyphenyl)piperazin- 1-yl)butyl]benzamide, a selective radioligand for dopamine D(3) receptors. I. In vitro characterization.

29. [State of neuromediator systems in rat cerebellum and brain stem upon single intake of morphine].

30. High precision liquid chromatography analysis of dopaminergic and serotoninergic responses to acute alcohol exposure in zebrafish.

31. Elevated levels of kynurenic acid change the dopaminergic response to amphetamine: implications for schizophrenia.

32. Zonisamide increases dopamine turnover in the striatum of mice and common marmosets treated with MPTP.

33. Accumbal dopamine and serotonin activity throughout acquisition and expression of place conditioning: correlative relationships with preference and aversion.

34. Nicotine effects on learning in zebrafish: the role of dopaminergic systems.

35. Influence of intrastriatal infusion of dynorphin fragments on overflow of acetylcholine and dopamine in the rat brain.

36. 1-Benzyl-1,2,3,4-tetrahydroisoquinoline, an endogenous parkinsonism-inducing toxin, strongly potentiates MAO-dependent dopamine oxidation and impairs dopamine release: ex vivo and in vivo neurochemical studies.

37. Effect of acute tryptophan depletion on noradrenaline and dopamine in the rat brain.

38. Selective antagonism at dopamine D3 receptors as a target for drug addiction pharmacotherapy: a review of preclinical evidence.

39. Asenapine increases dopamine, norepinephrine, and acetylcholine efflux in the rat medial prefrontal cortex and hippocampus.

40. Role of the dopamine transporter in the action of psychostimulants, nicotine, and other drugs of abuse.

41. The influence of acute and chronic administration of 1,2-dimethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline on the function of the nigrostriatal dopaminergic system in rats.

42. Preferential enhancement of dopamine transmission within the nucleus accumbens shell by cocaine is attributable to a direct increase in phasic dopamine release events.

43. Long-term administration of cocaine or serotonin reuptake inhibitors results in anatomical and neurochemical changes in noradrenergic, dopaminergic, and serotonin pathways.

44. Functional interactions between dopamine, serotonin and norepinephrine neurons: an in-vivo electrophysiological study in rats with monoaminergic lesions.

45. Juvenile methylphenidate modulates reward-related behaviors and cerebral blood flow by decreasing cortical D3 receptors.

46. Chronic ethanol exposure leads to divergent control of dopaminergic synapses in distinct target regions.

47. Baseline [18F]-FDOPA kinetics are predictive of haloperidol-induced changes in dopamine turnover and cognitive performance: A positron emission tomography study in healthy subjects.

48. Genetic or pharmacological blockade of noradrenaline synthesis enhances the neurochemical, behavioral, and neurotoxic effects of methamphetamine.

49. Pharmacological analysis of human D1 AND D2 dopamine receptor missense variants.

50. Clozapine normalizes prefrontal cortex dopamine transmission in monkeys subchronically exposed to phencyclidine.

Catalog

Books, media, physical & digital resources